Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
NCT ID:
NCT03264404
Group ID:
EG000
Title:
Pembrolizumab
Description:
Patients with advanced pancreatic cancer will receive pembrolizumab with the hypomethylating agent azacitidine.
Pembrolizumab: Pembrolizumab 200 mg IV every 3 weeks until progression
Azacitidine: 50 mg/m2 subcutaneous daily for 5 days every 28 days
Deaths Number Affected:
26
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
36
Other Number Affected:
36
Other Number At Risk:
36
Study:
NCT03264404
Results Section:
NCT03264404
Adverse Events Module:
NCT03264404